Filing Flows › Opus Genetics (IRD) › How it makes money
How Opus Genetics (IRD) makes money
Opus Genetics (IRD) made $755K of revenue in the second quarter 2026 (Q2 2026), -74% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $755K | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $755K | -74% |
| Q1 2026 | $2.2M | -51% |
| Q4 2025 | $3.9M | -10% |
| Q3 2025 | $3.1M | -20% |
| Q2 2025 | $2.9M | +159% |
| Q1 2025 | $4.4M | +155% |
| Q4 2024 | $4.3M | +154% |
From Opus Genetics' 10-Q filed Aug 6, 2026 (on EDGAR).
Questions
How does Opus Genetics make money?
Opus Genetics (IRD) made $755K of revenue in the second quarter 2026 (Q2 2026), -74% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.